{"id":332360,"date":"2026-10-29T14:34:33","date_gmt":"2026-10-29T09:04:33","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=332360"},"modified":"2026-10-29T14:34:33","modified_gmt":"2026-10-29T09:04:33","slug":"midcap-price-to-sales-ratio-above-6-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/midcap-price-to-sales-ratio-above-6-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Midcap Price to Sales Ratio Above 6 Stocks to Watch for Future Multibagger Potential: Max Healthcare, Phoenix Mills, Oberoi Realty and Ajanta Pharma"},"content":{"rendered":"

Max Healthcare Rs 851.50. Phoenix Mills Rs 1,899.30. Oberoi Realty Rs 1,601. Ajanta Pharma Rs 3,459.80. Market caps from Rs 43,550 crore to Rs 86,925 crore. Data as of 28 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Max Healthcare, Phoenix Mills, Oberoi Realty and Ajanta Pharma are the 4 picks in this price to sales ratio above 6 stocks watchlist, with market caps between Rs 43,550 crore and Rs 86,925 crore. Max Healthcare stands out for the largest market cap at Rs 86,925 crore, while Phoenix Mills offers the fastest profit growth, 58.28% a year since FY22. PE ratios run from 22.90 to 59.66, so compare each one with its industry PE before investing. All figures are as of 28 October 2026.<\/p>\n<\/p><\/div>\n

Price to sales ratio above 6 stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Max Healthcare, Phoenix Mills, Oberoi Realty and Ajanta Pharma meet that test, with market caps from Rs 43,550 crore to Rs 86,925 crore and Max Healthcare offering the largest market cap at Rs 86,925 crore. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a price to sales ratio above 6, which is market capitalisation divided by FY26 revenue, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n

This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a price to sales ratio above 6, which is market capitalisation divided by FY26 revenue, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening price to sales ratio above 6 stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n